Iron Chelating Agents: Promising Supportive Therapies in Severe Cases of COVID-19?
Dear Editor, On December 2019, new cases of COVID-19 pneumonia were reported from Wuhan city of China that were consequences of 2019-nCoV or SARS-CoV-2 infection (1). Very soon this disease spread around the world and till now over than 3,000,000 person have been infected with this new virus. The mo...
Main Authors: | Parisa Ghasemiyeh, Soliman Mohammadi-Samani |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2020-06-01
|
Series: | Trends in Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://tips.sums.ac.ir/article_46526_d6519379c6aa1291980547e5639d1a6f.pdf |
Similar Items
-
Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature
by: Mohamed Belmouhand, et al.
Published: (2021-07-01) -
Iron chelating agents for iron overload diseases
by: Guido Crisponi, et al.
Published: (2014-09-01) -
Combination therapies in iron chelation
by: Raffaella Origa
Published: (2014-12-01) -
Effects of iron chelating agent on Schistosoma mansoni infected murine model
by: Noha H. Abdelgelil, et al.
Published: (2019-01-01) -
Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review
by: M Hashemieh
Published: (2020-08-01)